Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568)

Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting

die Ergebnisse sind meines Erachtens erste Sahne.

http://finance.yahoo.com/news/Pfizer-and-Celldex-bw-15390816.html?.v=3